PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search > PAD Profile : Hyaluronic acid - Osteoarthritis

PAD Profile : Hyaluronic acid - Osteoarthritis Important

Keywords :
Sodium hyaluronate, synovial fluid, synovial joint injections,
Brand Names Include :
Durolane, Euflexxa, Fermathron, Hyalgan, Orthovisc, Ostenil, Suplasyn, Synocrom, Synopsis, Hylan GF, Synvisc ONE, Monovisc, Orthovisc, Synolis,
Important Information :
ASPH rehumatology only - Ostenil, Viscoseal and Synvisc

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Intra-articular injection
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network (PCN), during the update of the persistant non-malignant pain guidelines, does not recommend intra-articular hyaluronic acid injection in line with NICE guidance CG177. 

It may be suitable for individual patients for whom other pharmacological options have been intolerable or ineffective and who are unable to undergo surgery. Hyaluronic acid for these patients should be made available on an individual basis at the Acute Trust (this is not a Payment by Results Excluded drug and in individual cases GPs should not be asked to prescribe). (Discussed and agreed by PCN in January 2011)

Associated BNF Codes

No BNF codes returned.

This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More